EUCTR2015-000679-28-IT进行中（未招募）1 期
Prognostic value of 18F-FAZA PET/CT in high grade glioma: comparison with MRI and correlation with hypoxia biomarkers. - FAZA-gliomas
OSPEDALE SAN RAFFAELE0 个研究点目标入组 20 人开始时间: 2021年6月4日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- adult patients
- •- MRI suggestive of the presence of high-grade glioma
- •- indication of the performance of stereotactic biopsy
- •- patients are able to understand the study and release their consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 10
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 10
排除标准
- •- pregnancy and/or breastfeeding
- •- patients <18years
- •- inability to perform stereotactic biopsy
研究者
相似试验
已完成
不适用
The Prognostic Value of 18F-FDG PET/CT Taken Immediately After Completion of Radiotherapy for Lung Cancer Treated with Concurrent Chemoradiotherapy: A Pilot Studyung cancerJPRN-UMIN000037493Juntendo University Faculty of Medicine19
尚未招募
Unknown
The Prognostic Value of 18F-FDG PET/CT Taken Immediately After Completion of Radiotherapy for Lung Cancer Treated with Concurrent Chemoradiotherapy: Comparison between PET/CT taken after completion of adjuvant Durvalumabnon small cell lung cancerJPRN-UMIN000050438Juntendo University Faculty of Medicine Urayasu Hospital36
已完成
2 期
The predictive value of 18F-FLT-PET to demonstrate early haematological recovery in patients following autologous stem cell transplantation; a pilot study18F-FLT scan: transplantation10018849NL-OMON33499niversitair Medisch Centrum Groningen15
已完成
不适用
The predictive value of 18F-FDG-PET to demonstrate disease activity in patients with relapsed multiple myeloma; a pilot studyKahler's disease10018865NL-OMON32803niversitair Medisch Centrum Groningen15
已完成
3 期
Evaluation of 18F-FDHT PET/CT as a predictor of response in patients with metastasized castration-resistant prostate cancer to be treated with enzalutamide.10027476Prostate cancerNL-OMON41464niversitair Medisch Centrum Groningen60